Five different molecular pathways have been previously identified, leading to T-ALL, involving activation of different T-ALL oncogenes; HOX11, HOX11L2, TAL1, LMO1/2, LYL1, LMO2, and MLL-ENL. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.